Cargando…
Magnetic And pH Dual-Responsive Nanoparticles For Synergistic Drug-Resistant Breast Cancer Chemo/Photodynamic Therapy
BACKGROUND: Drug resistance is one of the prime reasons of chemotherapy failure in breast cancer and is also an important factor affecting prognosis. PURPOSE: In this study, we constructed a functional magnetic mesoporous silica-based nanocomposite (MMSN) for breast cancer chemotherapy/photodynamic...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6756767/ https://www.ncbi.nlm.nih.gov/pubmed/31571870 http://dx.doi.org/10.2147/IJN.S214377 |
_version_ | 1783453460936523776 |
---|---|
author | Wang, Dan Li, Xuefen Li, Xinfang Kang, Anfeng Sun, Linhong Sun, Miao Yang, Feng Xu, Congjian |
author_facet | Wang, Dan Li, Xuefen Li, Xinfang Kang, Anfeng Sun, Linhong Sun, Miao Yang, Feng Xu, Congjian |
author_sort | Wang, Dan |
collection | PubMed |
description | BACKGROUND: Drug resistance is one of the prime reasons of chemotherapy failure in breast cancer and is also an important factor affecting prognosis. PURPOSE: In this study, we constructed a functional magnetic mesoporous silica-based nanocomposite (MMSN) for breast cancer chemotherapy/photodynamic therapy. METHODS: MMSN was characterized by scanning electron microscopy and transmission electron microscopy to observe the morphology. The size distribution and zeta potential of the MSNs were determined using Malvern Particle Size Analyzer. Anti-tumor activity in vitro was investigated by CCK-8 assay, flow cytometry and transwell experiment, and the anti-tumor activity in vivo was probed into by magnetic targeting, toxicity, and antitumor effects in breast cancer-bearing BABL/c nude mice. RESULTS: The results showed that the release of doxorubicin in the nanocomposites was pH sensitive, and the cumulative release rate reached 80.53% at 60 h under acidic conditions. The nanocomposites had a high cellular uptake ability in MCF-7/ADR cells, and the IC(50) value of the nanocomposites on MCF-7/ADR cells was 4.23 μg/mL, much smaller than that of free DOX (363.2 μg/mL). The nanocomposites could effectively reverse resistance and induce apoptosis of MCF-7/ADR cells. The blood biochemistry parameters and H&E staining results showed no serious adverse effects after treatment with the nanocomposites. Prussian blue staining showed that the nanocomposites were able to target tumor tissues in tumor-bearing mice under a magnetic field. The combined chemical/photodynamic therapy significantly inhibited tumor growth in vivo. CONCLUSION: Nanocomposites with magnetic and pH dual-responsive performance has shown a promising platform for enhanced drug-resistant breast cancer treatment. |
format | Online Article Text |
id | pubmed-6756767 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Dove |
record_format | MEDLINE/PubMed |
spelling | pubmed-67567672019-09-30 Magnetic And pH Dual-Responsive Nanoparticles For Synergistic Drug-Resistant Breast Cancer Chemo/Photodynamic Therapy Wang, Dan Li, Xuefen Li, Xinfang Kang, Anfeng Sun, Linhong Sun, Miao Yang, Feng Xu, Congjian Int J Nanomedicine Original Research BACKGROUND: Drug resistance is one of the prime reasons of chemotherapy failure in breast cancer and is also an important factor affecting prognosis. PURPOSE: In this study, we constructed a functional magnetic mesoporous silica-based nanocomposite (MMSN) for breast cancer chemotherapy/photodynamic therapy. METHODS: MMSN was characterized by scanning electron microscopy and transmission electron microscopy to observe the morphology. The size distribution and zeta potential of the MSNs were determined using Malvern Particle Size Analyzer. Anti-tumor activity in vitro was investigated by CCK-8 assay, flow cytometry and transwell experiment, and the anti-tumor activity in vivo was probed into by magnetic targeting, toxicity, and antitumor effects in breast cancer-bearing BABL/c nude mice. RESULTS: The results showed that the release of doxorubicin in the nanocomposites was pH sensitive, and the cumulative release rate reached 80.53% at 60 h under acidic conditions. The nanocomposites had a high cellular uptake ability in MCF-7/ADR cells, and the IC(50) value of the nanocomposites on MCF-7/ADR cells was 4.23 μg/mL, much smaller than that of free DOX (363.2 μg/mL). The nanocomposites could effectively reverse resistance and induce apoptosis of MCF-7/ADR cells. The blood biochemistry parameters and H&E staining results showed no serious adverse effects after treatment with the nanocomposites. Prussian blue staining showed that the nanocomposites were able to target tumor tissues in tumor-bearing mice under a magnetic field. The combined chemical/photodynamic therapy significantly inhibited tumor growth in vivo. CONCLUSION: Nanocomposites with magnetic and pH dual-responsive performance has shown a promising platform for enhanced drug-resistant breast cancer treatment. Dove 2019-09-18 /pmc/articles/PMC6756767/ /pubmed/31571870 http://dx.doi.org/10.2147/IJN.S214377 Text en © 2019 Wang et al. http://creativecommons.org/licenses/by-nc/3.0/ This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php). |
spellingShingle | Original Research Wang, Dan Li, Xuefen Li, Xinfang Kang, Anfeng Sun, Linhong Sun, Miao Yang, Feng Xu, Congjian Magnetic And pH Dual-Responsive Nanoparticles For Synergistic Drug-Resistant Breast Cancer Chemo/Photodynamic Therapy |
title | Magnetic And pH Dual-Responsive Nanoparticles For Synergistic Drug-Resistant Breast Cancer Chemo/Photodynamic Therapy |
title_full | Magnetic And pH Dual-Responsive Nanoparticles For Synergistic Drug-Resistant Breast Cancer Chemo/Photodynamic Therapy |
title_fullStr | Magnetic And pH Dual-Responsive Nanoparticles For Synergistic Drug-Resistant Breast Cancer Chemo/Photodynamic Therapy |
title_full_unstemmed | Magnetic And pH Dual-Responsive Nanoparticles For Synergistic Drug-Resistant Breast Cancer Chemo/Photodynamic Therapy |
title_short | Magnetic And pH Dual-Responsive Nanoparticles For Synergistic Drug-Resistant Breast Cancer Chemo/Photodynamic Therapy |
title_sort | magnetic and ph dual-responsive nanoparticles for synergistic drug-resistant breast cancer chemo/photodynamic therapy |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6756767/ https://www.ncbi.nlm.nih.gov/pubmed/31571870 http://dx.doi.org/10.2147/IJN.S214377 |
work_keys_str_mv | AT wangdan magneticandphdualresponsivenanoparticlesforsynergisticdrugresistantbreastcancerchemophotodynamictherapy AT lixuefen magneticandphdualresponsivenanoparticlesforsynergisticdrugresistantbreastcancerchemophotodynamictherapy AT lixinfang magneticandphdualresponsivenanoparticlesforsynergisticdrugresistantbreastcancerchemophotodynamictherapy AT kanganfeng magneticandphdualresponsivenanoparticlesforsynergisticdrugresistantbreastcancerchemophotodynamictherapy AT sunlinhong magneticandphdualresponsivenanoparticlesforsynergisticdrugresistantbreastcancerchemophotodynamictherapy AT sunmiao magneticandphdualresponsivenanoparticlesforsynergisticdrugresistantbreastcancerchemophotodynamictherapy AT yangfeng magneticandphdualresponsivenanoparticlesforsynergisticdrugresistantbreastcancerchemophotodynamictherapy AT xucongjian magneticandphdualresponsivenanoparticlesforsynergisticdrugresistantbreastcancerchemophotodynamictherapy |